中国·尊龙(Z6)官方网站-MacauStore
尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2024.04.16
海普瑞：关于对深圳证券交易所2023年年报问询函回复的公告
2024.03.29
海普瑞：监事会对《董事会关于2023年度内部控制审计报告带强调事项段的无保留审计意见涉及事项的专项说明》的意见
2024.03.29
海普瑞：关于对会计师事务所2023年度履职情况评估报告
2024.03.29
海普瑞：独立董事2023年度述职报告（易铭）
2024.03.29
海普瑞：独立董事2023年度述职报告（王肈辉）
2024.03.29
海普瑞：独立董事2023年度述职报告（吕川）
2024.03.29
海普瑞：独立董事2023年度述职报告（黄鹏）
2024.03.29
海普瑞：独立董事2023年度述职报告（陈俊发）
2024.03.29
海普瑞：董事会审计委员会对会计师事务所2023年度履行监督职责情况报告
2024.03.29
海普瑞：董事会关于2023年度内部控制审计报告带强调事项段的无保留审计意见涉及事项的专项说明
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
尊龙
